Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Research & Development: 2020-2024

Historic Research & Development for Prime Medicine (PRME) over the last 5 years, with Dec 2024 value amounting to $155.3 million.

  • Prime Medicine's Research & Development rose 9.05% to $44.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $160.0 million, marking a year-over-year decrease of 1.61%. This contributed to the annual value of $155.3 million for FY2024, which is 4.99% up from last year.
  • Prime Medicine's Research & Development amounted to $155.3 million in FY2024, which was up 4.99% from $147.9 million recorded in FY2023.
  • Prime Medicine's Research & Development's 5-year high stood at $155.3 million during FY2024, with a 5-year trough of $3.0 million in FY2020.
  • For the 3-year period, Prime Medicine's Research & Development averaged around $130.0 million, with its median value being $147.9 million (2023).
  • Data for Prime Medicine's Research & Development shows a peak YoY spiked of 2,267.45% (in 2021) over the last 5 years.
  • Over the past 5 years, Prime Medicine's Research & Development (Yearly) stood at $3.0 million in 2020, then spiked by 2,267.45% to $70.5 million in 2021, then climbed by 22.93% to $86.7 million in 2022, then skyrocketed by 70.54% to $147.9 million in 2023, then climbed by 4.99% to $155.3 million in 2024.